Laura Pelletier

Exome sequencing of hepatocellular carcinomas identifies new mutational signatures and potential therapeutic targets

Kornelius Schulze, Sandrine Imbeaud, Éric Letouzé et al. · Nature Genetics · 2015 · 1.9K citations · Full text

Medicine, Genetics, Oncology +14

Integrated analysis of somatic mutations and focal copy-number changes identifies key genes and pathways in hepatocellular carcinoma

Cécile Guichard, Giuliana Amaddeo, Sandrine Imbeaud et al. · Nature Genetics · 2012 · 1.4K citations · Full text

Medicine, Molecular Genetics, Oncology +14

MicroRNA profiling in hepatocellular tumors is associated with clinical features and oncogene/tumor suppressor gene mutations

Yannick Ladeiro, Gabrielle Couchy, Charles Balabaud et al. · Hepatology · 2008 · 677 citations

Medicine, Oncology, Pathology +17

LLY-507, a Cell-active, Potent, and Selective Inhibitor of Protein-lysine Methyltransferase SMYD2

Hannah Nguyen, Abdellah Allali‐Hassani, Stephen Antonysamy et al. · Journal of Biological Chemistry · 2015 · 131 citations · Full text

Life Sciences, Medicinal Chemistry, Molecular Biology +11

Recurrent mutations of the exportin 1 gene (XPO1) and their impact on selective inhibitor of nuclear export compounds sensitivity in primary mediastinal B‐cell lymphoma

Fabrice Jardin, Anaïs Pujals, Laura Pelletier et al. · American Journal of Hematology · 2016 · 110 citations · Full text

Medicine, Cancer Biology, Oncology +14